Ganzel, C., Wang, X. V., Rowe, J. M., Richards, S. M., Buck, G., Marks, D. I., . . . Goldstone, A. H. (2020). At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial. Br J Haematol.

Ganzel, Chezi, et al. "At Three Years, Patients With Acute Lymphoblastic Leukaemia Are Still At Risk for Relapse. Results of the International MRC UKALLXII/ECOG E2993 Trial." Br J Haematol 2020.

Ganzel, Chezi, et al. "At Three Years, Patients With Acute Lymphoblastic Leukaemia Are Still At Risk for Relapse. Results of the International MRC UKALLXII/ECOG E2993 Trial." Br J Haematol 2020.